Lanean...
Towards a commercial process for the manufacture of genetically modified T cells for therapy
The recent successes of adoptive T-cell immunotherapy for the treatment of hematologic malignancies have highlighted the need for manufacturing processes that are robust and scalable for product commercialization. Here we review some of the more outstanding issues surrounding commercial scale manufa...
Gorde:
| Argitaratua izan da: | Cancer Gene Ther |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356749/ https://ncbi.nlm.nih.gov/pubmed/25613483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2014.78 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|